AAAAAA

   
Results: 1-18 |
Results: 18
Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile
Authors: Regazzi, MB Seminari, E Villani, P Carriero, PL Montagna, M Marubbi, F Maserati, R
Citation: Mb. Regazzi et al., Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile, J CHEMOTHER, 13(5), 2001, pp. 569-574
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV
Authors: Bruno, R Regazzi, MB Ciappina, V Villani, P Sacchi, P Montagna, M Panebianco, R Filice, G
Citation: R. Bruno et al., Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV, CLIN PHARMA, 40(9), 2001, pp. 695-700
Antiretrovirals: Simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography-mass spectrometry assay
Authors: Villani, P Feroggio, M Gianelli, L Bartoli, A Montagna, M Maserati, R Regazzi, MB
Citation: P. Villani et al., Antiretrovirals: Simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography-mass spectrometry assay, THER DRUG M, 23(4), 2001, pp. 380-388
Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy
Authors: Villani, P Viale, P Signorini, L Cadeo, B Marchetti, F Villani, A Fiocchi, C Regazzi, MB Carosi, G
Citation: P. Villani et al., Pharmacokinetic evaluation of oral levofloxacin in human immunodeficiency virus-infected subjects receiving concomitant antiretroviral therapy, ANTIM AG CH, 45(7), 2001, pp. 2160-2162
Pharmacokinetics of tacrolimus during the early phase after heart transplantation
Authors: Molinaro, M Regazzi, MB Pasquino, S Rinaldi, M Iacona, I Campana, C Vigano, M
Citation: M. Molinaro et al., Pharmacokinetics of tacrolimus during the early phase after heart transplantation, TRANSPLAN P, 33(3), 2001, pp. 2386-2389
Efavirenz, nelfiniavir, and stavudine rescue combination therapy in HIV-1-Positive patients heavily pretreated with nucleoside analogues and proteaseinhibitors (vol 22, pg 453, 1999)
Authors: Seminar, E Maggiolo, F Villani, P Suter, F Pan, A Regazzi, MB Paolucci, S Baldanti, F Tinelli, C Maserati, R
Citation: E. Seminar et al., Efavirenz, nelfiniavir, and stavudine rescue combination therapy in HIV-1-Positive patients heavily pretreated with nucleoside analogues and proteaseinhibitors (vol 22, pg 453, 1999), J ACQ IMM D, 23(3), 2000, pp. 278-278
Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients
Authors: Regazzi, MB Villani, P Maserati, R Seminari, E Pan, A LoCaputo, F Gambarana, E Fiocchi, C
Citation: Mb. Regazzi et al., Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients, J ANTIMICRO, 45(3), 2000, pp. 343-347
Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring of heart transplant recipients
Authors: Regazzi, MB Molinaro, M Tinelli, C D'Eril, GM Goggi, C Campana, C Fiorito, V Moratti, R Vigano, M
Citation: Mb. Regazzi et al., Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring of heart transplant recipients, THER DRUG M, 22(6), 2000, pp. 712-715
Rituximab (IDEC-C2B8): Validation of a sensitive enzyme-linked immunoassayapplied to a clinical pharmacokinetic study
Authors: Iacona, I Lazzarino, M Avanzini, MA Rupolo, M Arcaini, L Astori, C Lunghi, F Orlandi, E Morra, E Zagonel, V Regazzi, MB
Citation: I. Iacona et al., Rituximab (IDEC-C2B8): Validation of a sensitive enzyme-linked immunoassayapplied to a clinical pharmacokinetic study, THER DRUG M, 22(3), 2000, pp. 295-301
Influenza immunization and indinavir pharmacokinetics
Authors: Maserati, R Villani, P Barasolo, G Mongiovetti, M Regazzi, MB
Citation: R. Maserati et al., Influenza immunization and indinavir pharmacokinetics, SC J IN DIS, 32(4), 2000, pp. 449-450
Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors
Authors: Seminari, E Maggiolo, F Villani, P Suter, F Pan, A Regazzi, MB Tinelli, C Maserati, R
Citation: E. Seminari et al., Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors, J ACQ IMM D, 22(5), 1999, pp. 453-460
Epirubicin in a breast cancer patient with Gilbert's syndrome: Apparent lack of major pharmacokinetic alterations
Authors: Riggi, M Poggesi, I Regazzi, MB Grasso, S Fittipaldo, A Seematter, RJ
Citation: M. Riggi et al., Epirubicin in a breast cancer patient with Gilbert's syndrome: Apparent lack of major pharmacokinetic alterations, ANN ONCOL, 10(3), 1999, pp. 360-361
Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients
Authors: Villani, P Regazzi, MB Castelli, F Viale, P Torti, C Seminari, E Maserati, R
Citation: P. Villani et al., Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients, BR J CL PH, 48(5), 1999, pp. 712-715
Pharmacokinetic variability and strategy for therapeutic drug monitoring of saquinavir (SQV) in HIV-I infected individuals
Authors: Regazzi, MB Villani, P Maserati, R Cocchi, L Giacchino, R Burroni, D Rettani, M
Citation: Mb. Regazzi et al., Pharmacokinetic variability and strategy for therapeutic drug monitoring of saquinavir (SQV) in HIV-I infected individuals, BR J CL PH, 47(4), 1999, pp. 379-382
High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease
Authors: Maserati, R Villani, P Seminari, E Pan, A Lo Caputo, S Regazzi, MB
Citation: R. Maserati et al., High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease, AIDS, 13(7), 1999, pp. 870-871
High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma
Authors: Villani, P Pregnolato, M Banfo, S Rettani, M Burroni, D Seminari, E Maserati, R Regazzi, MB
Citation: P. Villani et al., High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma, THER DRUG M, 21(3), 1999, pp. 346-350
Clinical pharmacokinetics of tacrolimus in heart transplant recipients
Authors: Regazzi, MB Rinaldi, M Molinaro, M Pellegrini, C Calvi, M Arbustini, E Bellotti, E Bascape, V Martinelli, L Vigano, M
Citation: Mb. Regazzi et al., Clinical pharmacokinetics of tacrolimus in heart transplant recipients, THER DRUG M, 21(1), 1999, pp. 2-7
The effects of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischaemia
Authors: Mazzone, A Cusa, C Bucci, L Vezzoli, M Ghio, S Buggia, I Regazzi, MB Fossati, G Mazzucchelli, I Gritti, D
Citation: A. Mazzone et al., The effects of iloprost infusion on microcirculation is independent of nitric oxide metabolites and endothelin-1 in chronic peripheral ischaemia, EUR J CL IN, 29(1), 1999, pp. 1-5
Risultati: 1-18 |